Offline

Conf. Univ. Dr. Nicoleta Mariana Berbec

București30 years of experience5.0· 17 Reviews
Specialist certified by The Romanian College of PhysiciansCertified by RingdocSpecialist Certified by Ringdoc

Ringdoc: Telemedicine and Online Video Consultations Anywhere

Download the app for iOS or Android and request a medical consultation, either instantly or by appointment. Access verified Romanian doctors and receive electronic prescriptions directly on your phone, in complete safety (GDPR).

Download the Ringdoc telemedicine app for iPhoneDownload the Ringdoc telemedicine app for Android

Expert in:

LeukemiasLymphomasMyeloproliferative syndromesMultiple myelomaHemophiliaHematologic malignanciesDisorders of hemostasis and thrombosisPolycythemia vera

About me

Assoc. Prof. Dr. Nicoleta Berbec is a senior consultant in Clinical Hematology with over 25 years of experience in the diagnosis and treatment of hematological diseases. She has worked at Colțea Clinical Hospital, where she served as Head of the Hematology Department and Medical Director, and has held teaching positions at the “Carol Davila” University of Medicine and Pharmacy.

She holds certified competencies in hemobiology, molecular cytogenetics, and reconstructive transplant surgery. She has authored numerous scientific publications and has been involved in international research projects.

Patients can benefit from her expertise in conditions such as leukemias, lymphomas, and myeloproliferative syndromes, with a clinical approach grounded in the latest evidence-based treatments.

She is an active member of several prestigious professional societies, including the Romanian Society of Hematology (RSH), the European Hematology Association (EHA), and the European Society for Blood and Marrow Transplantation (EBMT).

Professional Experience

  • 1995 – 2008 | Assistant Professor | “Carol Davila” University of Medicine and Pharmacy, Bucharest | Department of Hematology M46 | Colțea Clinical Hospital – Hematology Department
  • 1996 – 2001 | Specialist Physician in Clinical Hematology | Hematology Department | Colțea Clinical Hospital
  • 2000 – 2006 | Senior Consultant (0.5 FTE) | Genetics Laboratory | National Institute for Research and Development “Victor Babeș”, Bucharest
  • 2001 – 2021 | Senior Consultant in Hematology | Hematology Department | Colțea Clinical Hospital
  • 2008 – 2016 | Lecturer | “Carol Davila” University of Medicine and Pharmacy, Bucharest | Department of Hematology M46 / Department 8 | Colțea Clinical Hospital
  • 2008 – 2017 | Head of the Hematology Department | Colțea Clinical Hospital
  • 2016 – 2021 | Associate Professor | “Carol Davila” University of Medicine and Pharmacy, Bucharest | Department 8 | Colțea Clinical Hospital
  • 2017 – 2021 | Medical Director | Colțea Clinical Hospital

Education and Training

  • 1991 | Medical Degree | Faculty of General Medicine | “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • 1992 | Medical Intern | Municipal Hospital of Bucharest
  • 1996 | Resident Physician | University Emergency Hospital, Bucharest
  • 1996 | Specialist Physician Examination | Hematology – Hemobiology
  • 1997 | Tempra Fellowship | Hematology | Edouard Herriot Hospital, Lyon, France
  • 1998 | Course: “Formation sur les produits dérivés du sang et leur environnement” | Lyon, France
  • 1998 | AFSA Internship – Faisant Fonction d’Interne | Hematology Department | Edouard Herriot Hospital, Lyon, France
  • 1999 | AFSA Internship | Claude Bernard University Lyon 1 | Hematology Department | Edouard Herriot Hospital, Lyon, France
  • 1999 | Seminar: “Erythrocyte Pathology and Blood Transfusion” | Bandol (Île de Bendor), France
  • 2001 | Senior Consultant in Clinical Hematology
  • 2006 | Multiple Myeloma Debate | Dublin, Ireland
  • 2007 | PhD in Medical Sciences
  • 2008 | Global Opinion Leader Summit (GOLS): Toward CML | Prague, Czech Republic
  • 2009 | Health Services Management | National School of Public Health Management
  • 2009 | New Developments in Multiple Myeloma | Monte Carlo, Monaco
  • 2011 | Molecular Cytogenetics Course (TDM)
  • 2013 | Postdoctoral Studies in Reconstructive Transplant Surgery | “Carol Davila” University of Medicine and Pharmacy, Bucharest
  • 2007 | Prescription and Use of Opioids in Pain Management | Ministry of Public Health
  • 2008 | Educational Course on Hemostasis and Thrombosis | Romanian Society of Hemostasis and Thrombosis
  • 2009 | ESH–EHA Type I Hematology Tutorial: Diagnostic Work-Up of Hematological Malignancies | Vienna, Austria
  • 2011 | CML GOLS 2011: Managing Chronic Myeloid Leukemia – Optimising Response, Improving Outcomes
  • 2011 | ELN Frontiers Meeting: New Frontiers in Myeloid Malignancies – Focus on CML, AML and MDS | Berlin, Germany
  • 2012 | Treatment and Transplantation in Acute Leukemias in Adults and Children | Mureș County College of Physicians
  • 2012 | Communication in the Physician–Patient Relationship | Bucharest College of Physicians
  • 2012 | ESH–EBMT 16th Training Course on Haematopoietic Stem Cell Transplantation | Sofia, Bulgaria
  • 2013 | Roche Clinical Trial Portal – Site User Tutorial | 25 April
  • 2013 | Introduction to the Clinical Drug Development Process: ICH Good Clinical Practice for Clinical Trial Sites
  • 2013 | PrefMab (EU-CEMAI) MO28457
  • 2013 | CML GOLS: Navigating Advances in CML Therapy – Steps Toward Treatment-Free Remission | Helsinki, Finland
  • 2013 | CML GOLS: Advancing Our Understanding of Myeloproliferative Neoplasms | 22–24 February | Helsinki, Finland
  • ICH Good Clinical Practice Training Certificate
  • 2014 | Lymphoma Guidelines: A Refresher
  • 2014 | Treating High-Risk CLL: Have Outcomes Improved?
  • 2014 | New Opportunities: Immunotherapies in Advanced NSCLC
  • 2014 | What’s New for Hemophilia?
  • 2014 | An Innovative Platform to Improve Patient Care in Multiple Myeloma
  • 2014 | Lymphoma Histopathology and the Clinic: A Working Partnership
  • 2015 | Targeting CD20 in NHL and CLL: Developing Current and Future Strategies
  • 2015 | Overcoming Barriers to Effective Management of Chronic Myeloid Leukemia

Certified Professional Competencies

  • Hemobiology
  • Molecular cytogenetics
  • Reconstructive transplant surgery

Scientific and Academic Activity

Published Books

  • Educational works and teaching materials developed in accordance with training curricula for medical students and residents, with relevance for other medical specialties
  • “Classic and Modern Aspects of Multiple Myeloma” | First Author | Semne Publishing House | 1998
  • “Acute Leukemias VIII – Prognostic Factors and Treatment Strategies” | Vol. 40, pp. 389–392 | Springer | 2001 | Co-author of the chapter “Treatment of Adult Acute Lymphoblastic Leukemia – Long-Term Results of a Prospective Study: LALA 87” | Edited by Prof. D. Fiere
  • “Fundamentals of Clinical Hematology” | Co-author | M.A.S.T. Publishing House | 2003 | Course textbook for 5th and 6th year medical students
  • “Clinical Hematology” | Co-author | “Carol Davila” University Press, Bucharest | 2004
  • “Question Collection for Hematology Clerkship Students” | Coordinator: Prof. Dr. Anca Roxana Lupu | “Carol Davila” University Press, Bucharest | 2014
  • “Pregnancy and Cancer: From Diagnosis to Treatment” | Medical Publishing House | 2015 | Sole author of the chapters: Lymphomas and Pregnancy; Acute Leukemias in Pregnancy; Chronic Myeloproliferative Neoplasms; Multiple Myeloma and Pregnancy
  • “Clinical Hematology” | Editors: Anca Roxana Lupu, Ana Maria Vladareanu, Daniel Coriu | “Carol Davila” University Press | 2017 | Co-author of 3 chapters
  • “Classical Cytogenetics in Malignant Hemopathies” | N. M. Berbec, M. O. D. Lupusoru, Delia Mut Popescu | Medical Publishing House | 2019

Published Articles

  • Acute lymphoblastic leukemia in the elderly: the Edouard Herriot Hospital experience | American Journal of Hematology | 67(2):73–83 | 2001
  • Philadelphia chromosome–positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome | Hematology and Cell Therapy | 40(3):119–128 | 1998
  • Abnormalities of platelet aggregation in chronic myeloproliferative disorders | Journal of Cellular and Molecular Medicine | 5(1):79–87 | 2001
  • Ropeginterferon alfa-2b versus standard therapy in polycythemia vera (PROUD-PV and CONTINUATION-PV studies): a randomized phase III trial | The Lancet Haematology | 7(3):e196–e208 | 2020
  • TERT rs2736100 A>C polymorphism and JAK2 46/1 haplotype in JAK2 V617F and CALR-mutated myeloproliferative neoplasms | British Journal of Haematology | 174(2):218–226 | 2016
  • MECOM, HBS1L-MYB, THRB-RARB, JAK2 and TERT polymorphisms in genetic predisposition to myeloproliferative neoplasms | American Journal of Hematology | 93(1):100–106 | 2018
  • Value of a multifaceted diagnostic approach in acute leukemias | Maedica | 7(3):254 | 2012
  • Clinical and therapeutic particularities of acute myeloid leukemia in elderly patients | Maedica | 6(4):287 | 2011
  • Increased plasma Dkk-1 levels as a marker for disease subtype differentiation in myeloproliferative neoplasms | Journal of Cellular and Molecular Medicine | 22(8):4005–4011 | 2018
  • Relationship between chromosomal complexity and disease aggressiveness in myeloid and lymphoid disorders | Journal of Cellular and Molecular Medicine | 6(3):389–398 | 2002
  • Co-occurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms | Blood | 132(25):2695–2699 | 2018
  • Von Willebrand disease type 2 in pregnancy – a critical clinical association | Transfusion and Apheresis Science | 56(3):269–271 | 2017
  • Eosinophil activation markers in clonal and non-clonal eosinophilia | Romanian Journal of Laboratory Medicine | 21(3):311–320 | 2013
  • Molecular characterization of complex chromosomal alterations in de novo acute myeloid leukemia | Romanian Journal of Laboratory Medicine | 21(1):59–65 | 2013
  • Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy | Journal of Medicine and Life | 5 (Special Issue):36 | 2012
  • Misinterpretation of hematological changes in pregnancy and postpartum hemorrhage due to leukemia | Journal of Reproductive Medicine | 62 | 2017
  • The APPLY study: darbepoetin alfa use in chemotherapy-induced anemia in Romania | Memo – Magazine of European Medical Oncology | 11(2):144–151 | 2018
  • Hypereosinophilic syndrome – case report | Internal Medicine | 12(5) | 2015
  • Association of “cup-like” blast morphology with NPM1 mutation in acute myeloid leukemia | Romanian Journal of Laboratory Medicine | 23(2):240–243 | 2015
  • Etiopathogenesis and prognostic implications of autoimmune hemolytic anemia associated with chronic lymphocytic leukemia | Journal of Medicine and Life | 5 (Special Issue):44 | 2012
  • Genetic technologies in cancer investigation – applications in aggressive lymphoid malignancies | Maedica | 7(1):75 | 2012
  • Genetic testing in myelodysplastic syndromes: contribution to diagnosis, prognosis and clinical management | Journal of Experimental and Molecular Biology | 11(2–3) | 2010
  • Activated protein C resistance and pregnancy – experience of the Hematology Departments of Colțea Clinical Hospital | Maedica – Journal of Clinical Medicine | 4(2):100 | 2009
  • Acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcomes | Blood | 94(10):224B | 1999
  • Philadelphia chromosome–positive adult acute lymphoblastic leukemia: clinical and cytogenetic characteristics, prognostic factors and treatment outcome | Blood | 90(10):3793 | 1997

I can speak with you in:

RomanianEnglish

Patients reviews

5.0· 17 Reviews
C. S.
15 January 2026

O experiență foarte bună cu dna dr. Berbec, hematolog, prin RingDoc. A fost extrem de implicată, mi-a oferit explicații detaliate și mi-a răspuns clar la toate întrebările. M-am simțit ascultată și lămurită. Mulțumesc!

A. K.
09 January 2026

Foarte empatica si profesionista

A. S.
19 November 2025

Un medic exceptional!Si mai ales, specializat pe probleme bariatrice.Multumesc din suflet dna doctor!